Quantitative determination of besifloxacin, a novel fluoroquinolone antimicrobial agent, in human tears by liquid chromatography-tandem mass spectrometry.
A rapid and sensitive method was developed using high-performance liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) for the quantification of besifloxacin in human tears using sparfloxacin as the internal standard (IS). Besifloxacin was extracted from human tear samples using an ammonium formate buffer at pH 3.25. The method was validated over a concentration range of 2-2000 ng/mL, with a total run time of less than 4 min. The overall intra- and inter-day precision for this method was less than 6%. The method was used to measure besifloxacin concentrations in tear samples collected after topical ocular administration to humans; besifloxacin concentrations were 610+/-540 microg/g (15 min) and 1.60+/-2.28 microg/g (24h).
Arnold
Dana R
DR
Global Preclinical Development, Bausch & Lomb, 1400 North Goodman Street, Rochester, NY 14609, USA.
Granvil
Camille P
CP
Ward
Keith W
KW
Proksch
Joel W
JW
D000900:Anti-Bacterial Agents / Q000032:analysis* / Q000493:pharmacokinetics; D001381:Azepines / Q000032:analysis* / Q000493:pharmacokinetics; D002138:Calibration; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D024841:Fluoroquinolones / Q000032:analysis* / Q000493:pharmacokinetics; D006801:Humans; D012015:Reference Standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry / Q000379:methods*; D013666:Tears / Q000737:chemistry*
D000900:Anti-Bacterial Agents; D001381:Azepines; D024841:Fluoroquinolones; C522124:besifloxacin